<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01541748</url>
  </required_header>
  <id_info>
    <org_study_id>CP009SU</org_study_id>
    <nct_id>NCT01541748</nct_id>
  </id_info>
  <brief_title>Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study</brief_title>
  <official_title>Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, single arm, multi-center, post-market study to evaluate the
      efficacy of Axis™ Allograft Dermis used for anterior, posterior or combined (anterior and
      posterior) pelvic organ prolapse repair.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate efficacy of the Axis Dermis graft used for soft tissue repair, replacement, reconstruction, or augmentations in the correction of POP as assessed by POP-Q Stage improvement</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess change in prolapse stage from baseline</measure>
    <time_frame>6 weeks, 6 months, 2 years, 3 years</time_frame>
    <description>Determined by POP-Q prolapse grading</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction and quality of life measurement</measure>
    <time_frame>6 weeks, 6 months, 2 years, 3 years</time_frame>
    <description>Measured through patient questionnaires PFDI-20, PFIQ-7, PISQ-12, PGI-I, SSQ-8, and Pelvic and Sexual Health VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary of AEs graded as mild, moderate, severe possibly or related to product and/or procedure and SAEs related to product and/or procedure</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">74</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Axis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Axis</intervention_name>
    <description>Coloplast's Axis™ Allograft Dermis consists of solvent-dehydrated, gamma-irradiated, preserved human collagen. It is restricted to homologus use as a soft tissue graft for horizontal and vertical soft tissue augmentation of thickness and length.</description>
    <arm_group_label>Axis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be adult female patients with pelvic organ prolapse, POP-Q Stage
        ≥ 2 that are clinically indicated for surgical intervention with Axis human tissue in the
        anterior, posterior, or combined (anterior and posterior) compartments at the institutions
        designated for this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult female at least 18 years of age.

          -  Willing and able to provide written informed consent.

          -  Confirmed pelvic organ prolapse (POP) of Stage 2 or higher as determined by POP-Q
             prolapse grading requiring surgical intervention in the anterior, posterior or
             combined (anterior and posterior) compartment.

          -  Willing and able to complete all follow-up visits and procedures indicated in this
             protocol.

        Exclusion Criteria:

          -  Concurrent surgical treatment of pelvic organ prolapse using anything other than the
             Axis Dermis.[Note: concurrent mid-urethral sling placement for treatment of stress
             urinary incontinence is allowed].

          -  Confirmed Stage 2 or higher prolapse as determined by POP-Q prolapse grading for a
             compartment that is not being repaired in the same procedure. (Concurrent POP-Q Stage
             1 repair is at the physician's discretion.)

          -  Previous pelvic organ prolapse repair using biologic, or synthetic grafts. [Note:
             previous midurethral sling for treatment of stress urinary incontinence is allowed]

          -  Pregnant or a desire to become pregnant in the future.

          -  Previous radiation or other treatments for cancer in the pelvic area.

          -  Severe urogenital atrophy.

          -  Immunosuppression and/or current systemic steroid user.

          -  Any contraindication to the surgical procedure.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristine Whitmore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Philadelphia Urosurgical Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Urogynecology Associates</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Female Pelvic Medicine and Urogynecology Institute of MI</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Institute for Female Pelvic Medicine and Reconstructive Surgery</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Philadelphia Urosurgical Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2012</study_first_submitted>
  <study_first_submitted_qc>February 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2012</study_first_posted>
  <last_update_submitted>July 19, 2017</last_update_submitted>
  <last_update_submitted_qc>July 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

